RN7SL424P

Across TCGA pan-cancer cohorts, RN7SL424P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL424P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RN7SL424P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL424P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

KIRP, LIHC, and BLCA are the cancer types where RN7SL424P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.428	0.923	<.001	81	view →
LIHC	OS	Tertile	All	0.089	0.783	<.001	72	view →
BLCA	OS	Tertile	All	0.141	0.687	.003	54	view →
KIRC	DFS	Tertile	III,IV	0.159	0.482	.002	36	view →
UCEC	DFS	Tertile	All	0.423	0.654	.008	36	view →
COAD	OS	Tertile	III,IV	0.140	0.792	<.001	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
ESCA	OS	Tertile	All	0.211	0.876	.028	18	view →
LAML	DFS	Tertile	All	1.000	0.349	.041	12	view →
LGG	DFS	Tertile	All	0.548	0.742	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL424P–KIRP (DFS)

Open the KIRP breakdown →